On June 16, SpaceX signed a $60 billion all-stock agreement to buy Anysphere — the company behind Cursor, the AI coding tool millions of developers open every morning. A rocket company bought a code editor. Read that again. The headline is the price. The story is what it tells you about where value is actually moving, and why the same logic that justifies a $60 billion check should change how you build your own business.

In November 2025, a teenager defended his doctoral thesis in quantum physics at the University of Antwerp. He was fifteen years old. The day after his defense, he flew to Munich and started a second PhD — this time in medicine and artificial intelligence.

The internet made him a curiosity. We think the headline misses the real lesson entirely. Strip away the prodigy framing and what is left is a clean case study in the three forces that decide who wins the next decade — and none of them require genius.

There is a quiet contradiction running through almost every company shipping AI right now. They are racing to give agents the keys — to inboxes, to codebases, to customer data, to the ability to act — and almost none of them have asked the only question that matters once an agent can act: what happens when someone turns it against you.

On May 27, 2026, Anthropic — the company that builds Claude — published a 36-page guide called Zero Trust for AI Agents. Read the subtext and it is remarkable: the firm with the most to gain from agents being trusted spent 36 pages explaining why they should not be. Not as a warning about some distant future. As a description of attacks happening in production today.

We read it the way we read everything: as operators who have to put this into the field, not admire it from a distance. And it confirmed, in heavier language than we use, something we say constantly: An agent isn't an agent. It's an organized file structure.

That one sentence is the whole security story. Strip away the mystique and an "agent" is not a being with intent. It is instructions, context, memory, and tool definitions — text, organized into a structure the model reads top to bottom and then acts on. There is no ghost in it. There is a file structure, and the model does what the structure tells it to do. Hold that picture and Anthropic's entire 36 pages snap into focus. Every threat they name is an attack on the file structure. Every defense they prescribe is discipline imposed on that same structure. Secure the structure and you secure the agent.

A medicine used to take a decade to find. A company just raised $2.1 billion to make that timeline collapse to days.

On May 12, 2026, Isomorphic Labs closed a $2.1 billion Series B led by Thrive Capital, with Alphabet, GV, MGX, Temasek, CapitalG, and the UK Sovereign AI Fund all writing checks. The Google DeepMind spin-off, run by Demis Hassabis, has a mission stated without flinching: design medicine for every disease on earth.

The headline is the money. The lesson sits underneath it. What Isomorphic actually built is not a drug. It is an engine. And the gap between owning an engine and doing the work by hand is the same gap that separates the companies that compound from the ones that grind. That gap is what we want you to look at.